- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Psilocybin Assisted Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Psilocybin Assisted Therapy size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Psilocybin Assisted Therapy market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
Psilocybin Assisted Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Natural
Synthetic
Market segment by Application can be divided into
Cluster Headaches
Anxiety Disorders
Psychiatric Disorders
The key market players for global Psilocybin Assisted Therapy market are listed below:
MindMed
Compass Pathways
ATAI Life Sciences
Field Trip
DemeRx
Eleusis
Hikma Pharmaceuticals PLC
Pfizer
Verrian
Jazz Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Psilocybin Assisted Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Psilocybin Assisted Therapy, with price, sales, revenue and global market share of Psilocybin Assisted Therapy from 2019 to 2021.
Chapter 3, the Psilocybin Assisted Therapy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Psilocybin Assisted Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Psilocybin Assisted Therapy market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Psilocybin Assisted Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Psilocybin Assisted Therapy Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Psilocybin Assisted Therapy Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Natural
1.2.3 Synthetic
1.3 Market Analysis by Application
1.3.1 Overview: Global Psilocybin Assisted Therapy Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Cluster Headaches
1.3.3 Anxiety Disorders
1.3.4 Psychiatric Disorders
1.4 Global Psilocybin Assisted Therapy Market Size & Forecast
1.4.1 Global Psilocybin Assisted Therapy Sales in Value (2016-2026))
1.4.2 Global Psilocybin Assisted Therapy Sales in Volume (2016-2026)
1.4.3 Global Psilocybin Assisted Therapy Price by Type (2016-2026) & (US$/Unit)
1.5 Global Psilocybin Assisted Therapy Production Capacity Analysis
1.5.1 Global Psilocybin Assisted Therapy Total Production Capacity (2016-2026)
1.5.2 Global Psilocybin Assisted Therapy Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Psilocybin Assisted Therapy Market Drivers
1.6.2 Psilocybin Assisted Therapy Market Restraints
1.6.3 Psilocybin Assisted Therapy Trends Analysis
2 Manufacturers Profiles
2.1 MindMed
2.1.1 MindMed Details
2.1.2 MindMed Major Business
2.1.3 MindMed Psilocybin Assisted Therapy Product and Services
2.1.4 MindMed Psilocybin Assisted Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Compass Pathways
2.2.1 Compass Pathways Details
2.2.2 Compass Pathways Major Business
2.2.3 Compass Pathways Psilocybin Assisted Therapy Product and Services
2.2.4 Compass Pathways Psilocybin Assisted Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 ATAI Life Sciences
2.3.1 ATAI Life Sciences Details
2.3.2 ATAI Life Sciences Major Business
2.3.3 ATAI Life Sciences Psilocybin Assisted Therapy Product and Services
2.3.4 ATAI Life Sciences Psilocybin Assisted Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Field Trip
2.4.1 Field Trip Details
2.4.2 Field Trip Major Business
2.4.3 Field Trip Psilocybin Assisted Therapy Product and Services
2.4.4 Field Trip Psilocybin Assisted Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 DemeRx
2.5.1 DemeRx Details
2.5.2 DemeRx Major Business
2.5.3 DemeRx Psilocybin Assisted Therapy Product and Services
2.5.4 DemeRx Psilocybin Assisted Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Eleusis
2.6.1 Eleusis Details
2.6.2 Eleusis Major Business
2.6.3 Eleusis Psilocybin Assisted Therapy Product and Services
2.6.4 Eleusis Psilocybin Assisted Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Hikma Pharmaceuticals PLC
2.7.1 Hikma Pharmaceuticals PLC Details
2.7.2 Hikma Pharmaceuticals PLC Major Business
2.7.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product and Services
2.7.4 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Psilocybin Assisted Therapy Product and Services
2.8.4 Pfizer Psilocybin Assisted Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Verrian
2.9.1 Verrian Details
2.9.2 Verrian Major Business
2.9.3 Verrian Psilocybin Assisted Therapy Product and Services
2.9.4 Verrian Psilocybin Assisted Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Jazz Pharmaceuticals
2.10.1 Jazz Pharmaceuticals Details
2.10.2 Jazz Pharmaceuticals Major Business
2.10.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product and Services
2.10.4 Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Psilocybin Assisted Therapy Sales by Manufacturer
3.1 Global Psilocybin Assisted Therapy Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Psilocybin Assisted Therapy Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Psilocybin Assisted Therapy
3.4 Market Concentration Rate
3.4.1 Top 3 Psilocybin Assisted Therapy Manufacturer Market Share
3.4.2 Top 6 Psilocybin Assisted Therapy Manufacturer Market Share
3.5 Global Psilocybin Assisted Therapy Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Psilocybin Assisted Therapy Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Psilocybin Assisted Therapy Market Size by Region
4.1.1 Global Psilocybin Assisted Therapy Sales in Volume by Region (2016-2026)
4.1.2 Global Psilocybin Assisted Therapy Revenue by Region (2016-2026)
4.2 North America Psilocybin Assisted Therapy Revenue (2016-2026)
4.3 Europe Psilocybin Assisted Therapy Revenue (2016-2026)
4.4 Asia-Pacific Psilocybin Assisted Therapy Revenue (2016-2026)
4.5 South America Psilocybin Assisted Therapy Revenue (2016-2026)
4.6 Middle East and Africa Psilocybin Assisted Therapy Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Psilocybin Assisted Therapy Sales in Volume by Type (2016-2026)
5.2 Global Psilocybin Assisted Therapy Revenue by Type (2016-2026)
5.3 Global Psilocybin Assisted Therapy Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Psilocybin Assisted Therapy Sales in Volume by Application (2016-2026)
6.2 Global Psilocybin Assisted Therapy Revenue by Application (2016-2026)
6.3 Global Psilocybin Assisted Therapy Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Psilocybin Assisted Therapy Sales by Type (2016-2026)
7.2 North America Psilocybin Assisted Therapy Sales by Application (2016-2026)
7.3 North America Psilocybin Assisted Therapy Market Size by Country
7.3.1 North America Psilocybin Assisted Therapy Sales in Volume by Country (2016-2026)
7.3.2 North America Psilocybin Assisted Therapy Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Psilocybin Assisted Therapy Sales by Type (2016-2026)
8.2 Europe Psilocybin Assisted Therapy Sales by Application (2016-2026)
8.3 Europe Psilocybin Assisted Therapy Market Size by Country
8.3.1 Europe Psilocybin Assisted Therapy Sales in Volume by Country (2016-2026)
8.3.2 Europe Psilocybin Assisted Therapy Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Psilocybin Assisted Therapy Sales by Type (2016-2026)
9.2 Asia-Pacific Psilocybin Assisted Therapy Sales by Application (2016-2026)
9.3 Asia-Pacific Psilocybin Assisted Therapy Market Size by Region
9.3.1 Asia-Pacific Psilocybin Assisted Therapy Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Psilocybin Assisted Therapy Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Psilocybin Assisted Therapy Sales by Type (2016-2026)
10.2 South America Psilocybin Assisted Therapy Sales by Application (2016-2026)
10.3 South America Psilocybin Assisted Therapy Market Size by Country
10.3.1 South America Psilocybin Assisted Therapy Sales in Volume by Country (2016-2026)
10.3.2 South America Psilocybin Assisted Therapy Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Psilocybin Assisted Therapy Sales by Type (2016-2026)
11.2 Middle East & Africa Psilocybin Assisted Therapy Sales by Application (2016-2026)
11.3 Middle East & Africa Psilocybin Assisted Therapy Market Size by Country
11.3.1 Middle East & Africa Psilocybin Assisted Therapy Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Psilocybin Assisted Therapy Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Psilocybin Assisted Therapy Typical Distributors
12.3 Psilocybin Assisted Therapy Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Psilocybin Assisted Therapy Revenue by Type, (USD Million), 2021-2026
Table 2. Global Psilocybin Assisted Therapy Revenue by Application, (USD Million), 2021-2026
Table 3. MindMed Basic Information, Manufacturing Base and Competitors
Table 4. MindMed Major Business
Table 5. MindMed Psilocybin Assisted Therapy Product and Services
Table 6. MindMed Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Compass Pathways Basic Information, Manufacturing Base and Competitors
Table 8. Compass Pathways Major Business
Table 9. Compass Pathways Psilocybin Assisted Therapy Product and Services
Table 10. Compass Pathways Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. ATAI Life Sciences Basic Information, Manufacturing Base and Competitors
Table 12. ATAI Life Sciences Major Business
Table 13. ATAI Life Sciences Psilocybin Assisted Therapy Product and Services
Table 14. ATAI Life Sciences Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Field Trip Basic Information, Manufacturing Base and Competitors
Table 16. Field Trip Major Business
Table 17. Field Trip Psilocybin Assisted Therapy Product and Services
Table 18. Field Trip Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. DemeRx Basic Information, Manufacturing Base and Competitors
Table 20. DemeRx Major Business
Table 21. DemeRx Psilocybin Assisted Therapy Product and Services
Table 22. DemeRx Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Eleusis Basic Information, Manufacturing Base and Competitors
Table 24. Eleusis Major Business
Table 25. Eleusis Psilocybin Assisted Therapy Product and Services
Table 26. Eleusis Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Hikma Pharmaceuticals PLC Basic Information, Manufacturing Base and Competitors
Table 28. Hikma Pharmaceuticals PLC Major Business
Table 29. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product and Services
Table 30. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Major Business
Table 33. Pfizer Psilocybin Assisted Therapy Product and Services
Table 34. Pfizer Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Verrian Basic Information, Manufacturing Base and Competitors
Table 36. Verrian Major Business
Table 37. Verrian Psilocybin Assisted Therapy Product and Services
Table 38. Verrian Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Jazz Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Jazz Pharmaceuticals Major Business
Table 41. Jazz Pharmaceuticals Psilocybin Assisted Therapy Product and Services
Table 42. Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Psilocybin Assisted Therapy Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Psilocybin Assisted Therapy Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Psilocybin Assisted Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Psilocybin Assisted Therapy Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Psilocybin Assisted Therapy Production Site of Key Manufacturer
Table 48. Psilocybin Assisted Therapy New Entrant and Capacity Expansion Plans
Table 49. Psilocybin Assisted Therapy Mergers & Acquisitions in the Past Five Years
Table 50. Global Psilocybin Assisted Therapy Sales by Region (2016-2021e) & (K Units)
Table 51. Global Psilocybin Assisted Therapy Sales by Region (2021-2026) & (K Units)
Table 52. Global Psilocybin Assisted Therapy Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Psilocybin Assisted Therapy Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Psilocybin Assisted Therapy Sales by Type (2016-2021e) & (K Units)
Table 55. Global Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units)
Table 56. Global Psilocybin Assisted Therapy Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Psilocybin Assisted Therapy Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Psilocybin Assisted Therapy Price by Type (2016-2021e) & (US$/Unit)
Table 59. Global Psilocybin Assisted Therapy Price by Type (2021-2026) & (US$/Unit)
Table 60. Global Psilocybin Assisted Therapy Sales by Application (2016-2021e) & (K Units)
Table 61. Global Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units)
Table 62. Global Psilocybin Assisted Therapy Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Psilocybin Assisted Therapy Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Psilocybin Assisted Therapy Price by Application (2016-2021e) & (US$/Unit)
Table 65. Global Psilocybin Assisted Therapy Price by Application (2021-2026) & (US$/Unit)
Table 66. North America Psilocybin Assisted Therapy Sales by Country (2016-2021e) & (K Units)
Table 67. North America Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units)
Table 68. North America Psilocybin Assisted Therapy Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Psilocybin Assisted Therapy Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Psilocybin Assisted Therapy Sales by Type (2016-2021e) & (K Units)
Table 71. North America Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units)
Table 72. North America Psilocybin Assisted Therapy Sales by Application (2016-2021e) & (K Units)
Table 73. North America Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units)
Table 74. Europe Psilocybin Assisted Therapy Sales by Country (2016-2021e) & (K Units)
Table 75. Europe Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units)
Table 76. Europe Psilocybin Assisted Therapy Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Psilocybin Assisted Therapy Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Psilocybin Assisted Therapy Sales by Type (2016-2021e) & (K Units)
Table 79. Europe Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units)
Table 80. Europe Psilocybin Assisted Therapy Sales by Application (2016-2021e) & (K Units)
Table 81. Europe Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units)
Table 82. Asia-Pacific Psilocybin Assisted Therapy Sales by Region (2016-2021e) & (K Units)
Table 83. Asia-Pacific Psilocybin Assisted Therapy Sales by Region (2021-2026) & (K Units)
Table 84. Asia-Pacific Psilocybin Assisted Therapy Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Psilocybin Assisted Therapy Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Psilocybin Assisted Therapy Sales by Type (2016-2021e) & (K Units)
Table 87. Asia-Pacific Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units)
Table 88. Asia-Pacific Psilocybin Assisted Therapy Sales by Application (2016-2021e) & (K Units)
Table 89. Asia-Pacific Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units)
Table 90. South America Psilocybin Assisted Therapy Sales by Country (2016-2021e) & (K Units)
Table 91. South America Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units)
Table 92. South America Psilocybin Assisted Therapy Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Psilocybin Assisted Therapy Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Psilocybin Assisted Therapy Sales by Type (2016-2021e) & (K Units)
Table 95. South America Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units)
Table 96. South America Psilocybin Assisted Therapy Sales by Application (2016-2021e) & (K Units)
Table 97. South America Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units)
Table 98. Middle East & Africa Psilocybin Assisted Therapy Sales by Country (2016-2021e) & (K Units)
Table 99. Middle East & Africa Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units)
Table 100. Middle East & Africa Psilocybin Assisted Therapy Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Psilocybin Assisted Therapy Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Psilocybin Assisted Therapy Sales by Type (2016-2021e) & (K Units)
Table 103. Middle East & Africa Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units)
Table 104. Middle East & Africa Psilocybin Assisted Therapy Sales by Application (2016-2021e) & (K Units)
Table 105. Middle East & Africa Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Psilocybin Assisted Therapy Typical Distributors
Table 109. Psilocybin Assisted Therapy Typical Customers
List of Figures
Figure 1. Psilocybin Assisted Therapy Picture
Figure 2. Global Psilocybin Assisted Therapy Sales Market Share by Type in 2020
Figure 3. Natural
Figure 4. Synthetic
Figure 5. Global Psilocybin Assisted Therapy Sales Market Share by Application in 2020
Figure 6. Cluster Headaches
Figure 7. Anxiety Disorders
Figure 8. Psychiatric Disorders
Figure 9. Global Psilocybin Assisted Therapy Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Psilocybin Assisted Therapy Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Psilocybin Assisted Therapy Sales (2016-2026) & (K Units)
Figure 12. Global Psilocybin Assisted Therapy Price by Type (2016-2026) & (US$/Unit)
Figure 13. Global Psilocybin Assisted Therapy Production Capacity (2016-2026) & (K Units)
Figure 14. Global Psilocybin Assisted Therapy Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Psilocybin Assisted Therapy Market Drivers
Figure 16. Psilocybin Assisted Therapy Market Restraints
Figure 17. Psilocybin Assisted Therapy Market Trends
Figure 18. Global Psilocybin Assisted Therapy Sales Market Share by Manufacturer in 2020
Figure 19. Global Psilocybin Assisted Therapy Revenue Market Share by Manufacturer in 2020
Figure 20. Psilocybin Assisted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Psilocybin Assisted Therapy Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Psilocybin Assisted Therapy Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Psilocybin Assisted Therapy Sales Market Share by Region (2016-2026)
Figure 24. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2016-2026)
Figure 25. North America Psilocybin Assisted Therapy Revenue (2016-2026) & (USD Million)
Figure 26. Europe Psilocybin Assisted Therapy Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Psilocybin Assisted Therapy Revenue (2016-2026) & (USD Million)
Figure 28. South America Psilocybin Assisted Therapy Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Psilocybin Assisted Therapy Revenue (2016-2026) & (USD Million)
Figure 30. Global Psilocybin Assisted Therapy Sales Market Share by Type (2016-2026)
Figure 31. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2016-2026)
Figure 32. Global Psilocybin Assisted Therapy Price by Type (2016-2026) & (US$/Unit)
Figure 33. Global Psilocybin Assisted Therapy Sales Market Share by Application (2016-2026)
Figure 34. Global Psilocybin Assisted Therapy Revenue Market Share by Application (2016-2026)
Figure 35. Global Psilocybin Assisted Therapy Price by Application (2016-2026) & (US$/Unit)
Figure 36. North America Psilocybin Assisted Therapy Sales Market Share by Type (2016-2026)
Figure 37. North America Psilocybin Assisted Therapy Sales Market Share by Application (2016-2026)
Figure 38. North America Psilocybin Assisted Therapy Sales Market Share by Country (2016-2026)
Figure 39. North America Psilocybin Assisted Therapy Revenue Market Share by Country (2016-2026)
Figure 40. United States Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Psilocybin Assisted Therapy Sales Market Share by Type (2016-2026)
Figure 44. Europe Psilocybin Assisted Therapy Sales Market Share by Application (2016-2026)
Figure 45. Europe Psilocybin Assisted Therapy Sales Market Share by Country (2016-2026)
Figure 46. Europe Psilocybin Assisted Therapy Revenue Market Share by Country (2016-2026)
Figure 47. Germany Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Psilocybin Assisted Therapy Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Psilocybin Assisted Therapy Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Psilocybin Assisted Therapy Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Psilocybin Assisted Therapy Revenue Market Share by Region (2016-2026)
Figure 56. China Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Psilocybin Assisted Therapy Sales Market Share by Type (2016-2026)
Figure 63. South America Psilocybin Assisted Therapy Sales Market Share by Application (2016-2026)
Figure 64. South America Psilocybin Assisted Therapy Sales Market Share by Country (2016-2026)
Figure 65. South America Psilocybin Assisted Therapy Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Psilocybin Assisted Therapy Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Psilocybin Assisted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
